(Q44160406)

30 November 2017

Mupirocin vs terbinafine in impetigo (English)

1 reference

30 November 2017

0 references

1 reference

Ergin Ciftci

1

1 reference

PubMed ID

12356219

30 November 2017

Haluk Guriz

series ordinal

2

1 reference

PubMed ID

12356219

30 November 2017

Ahmet Derya Aysev

series ordinal

3

1 reference

30 November 2017

1 August 2002

1 reference

Indian Journal of Pediatrics

30 November 2017

1 reference

30 November 2017

69

1 reference

30 November 2017

8

1 reference

30 November 2017

679-682

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02722704

30 November 2017

0 references

cites work

Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02722704

Comparison of mupirocin and erythromycin in the treatment of impetigo

21 January 2018

1 reference

12 December 2020

Clinical relevance of the antibacterial activity of terbinafine: a contralateral comparison between 1% terbinafine cream and 0.1% gentamicin sulphate cream in pyoderma

1 reference

12 December 2020

Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo

1 reference

12 December 2020

Microbiology of secondarily infected diaper dermatitis

1 reference

12 December 2020

Interdigital athlete's foot. The interaction of dermatophytes and resident bacteria

1 reference

12 December 2020

Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02722704

1 reference

30 November 2017

1 reference

PubMed ID

12356219